The Trump administration asked the Supreme Court on Monday to let it enforce, for now, restrictions on gender-affirming care ...
Merck discontinued Recarbio, an important antibiotic in the U.S., despite concerns over resistance to superbugs.
Post-wildfire air quality needs to be monitored long term, suggests a study finding Maui residents had high levels of toxic ...
The FDA has approved AbbVie’s once-daily Parkinson’s pill for sales, based on a late-stage study that showed the drug helped ...
Late Friday night, the Trump administration clawed back nearly $1 billion in spending approved by Congress, targeting several ...
Once promoted as tools to address obesity as a medical issue, GLP-1 drugs are increasingly being seen — and marketed — as a ...
Defenses against AI-created bioweapons will take years to build. We don’t have years to spare,” writes Ashish Jha.
Blockbuster GLP-1 drugs have transformed the lives of millions of people. Lately, they’re undergoing a makeover of their own.
Our finding was remarkable because it had remained hidden within one of the best-studied organs in medical history.
The Justice Department said in June that it would no longer enforce laws that prioritized people with disabilities living and ...
At least five candidates are in the running to become the next director-general of the WHO, a job that will come with ...
President Trump is canceling nearly $1 billion in spending approved by Congress, and most of the cuts are focused on HHS programs that serve refugees and unaccompanied minors.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results